| Project/Area Number |
15K18902
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Drug development chemistry
|
|---|
| Research Institution | Kyoto Pharmaceutical University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
AKAJI Kenichi 京都薬科大学, 薬学部, 教授 (60142296)
HATTORI Yasunao 京都薬科大学, 薬学部, 助教 (20567028)
|
|---|
| Project Period (FY) |
2015-04-01 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | アルツハイマー病 / BACE1 / 低分子阻害剤 / アミジノ基 / ピロリジン / ピペリジン |
|---|
| Outline of Final Research Achievements |
I have investigated to develop novel small molecule β-secretase (BACE1) inhibitors based on an N-amidino nitrogen-containing ring structure. Focusing on amidino-pyrrolidine and amidino-piperidine as the structure, I synthesized several derivatives, and evaluated their BACE1 inhibitory activity. The structure-activity relationship study suggested that two balky substituents located on a five- or six-ring structure with trans-configuration contributed to the bioactivity.
|
